Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro

Bone marrow mesenchymal stromal cells (BM-MSCs) have been characterized and used in many clinical studies based on their immunomodulatory and regenerative properties. We have recently reported the benefit of autologous MSC systemic therapy in the treatment of type 1 diabetes mellitus (T1D). Compared...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Davies, Lindsay C., Alm, Jessica J., Heldring, Nina, Moll, Guido, Gavin, Caroline, Batsis, Ioannis, Qian, Hong, Sigvardsson, Mikael, Nilsson, Bo, Kyllonen, Lauri E., Salmela, Kaija T., Carlsson, Per-Ola, Korsgren, Olle, Le Blanc, Katarina
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Tissue-Specific Progenitor and Stem Cells
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070499/
https://ncbi.nlm.nih.gov/pubmed/27412884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0272
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados